Clinical Trial Update: Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

NIMH-sponsored Phase 4 clinical trial comparing antipsychotics for metabolic problems in schizophrenia and schizoaffective disorder with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-12-19